[Use of the new neuroleptic drug leptril in psychiatric practice].
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D001927:Brain Diseases / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002648:Child; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006993:Hypnotics and Sedatives; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008875:Middle Aged; D010640:Phenothiazines; D010880:Piperidines / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D012640:Seizures / Q000188:drug therapy
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D010880:Piperidines
O primenenii novogo neĭroleptika leptrila v psikhiatricheskoĭ praktike.